The Avidity and Lytic Efficiency of the CTL Response to HTLV-11

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5723-5729

  Kattan, Tarek ^a   MacNamara, Aidan ^a   Rowan, Aileen G ^a   Nose, Hirohisa ^a   Mosley, Angelina J ^b   Tanaka, Yuetsu ^c   Taylor, Graham P ^a   Asquith, Becca ^a   Bangham, Charles R M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; TAX PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOGENETICS; IN VIVO STUDY; INFLAMMATORY DISEASE; MICROARRAY ANALYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; ANTIGEN PRESENTATION; CELL ADHESION; CELL CULTURE; CELL LINE; CHRONIC DISEASE; CYTOTOXICITY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; RAT; SPASTIC PARAPLEGIA; T CELL LEUKEMIA; TUMOR CELL LINE; VIROLOGY;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHRONIC DISEASE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PARAPARESIS, TROPICAL SPASTIC; PROVIRUSES; RATS; VIRAL LOAD;

EID: 66949118598     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900069     Document Type: Article

References (42)

1. Nagai, M., K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo, and M. Osame. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4: 586-593. (Pubitemid 29042065)
2. Bangham, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24: 6035-6046.
3. Jeffery, K. J., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, et al. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96: 3848-3853.
4. + cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res. Hum. Retroviruses 16: 1705-1709.
5. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
6. Jacobson, S. 2002. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J. Infect. Dis. 186 (Suppl 2): S187-S192. (Pubitemid 35370480)
7. + lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J. Immunol. 173: 5121-5129.
8. + T cells: frequency and immunodominance hierarchy. J. Infect. Dis. 189: 2294-2298.
9. Elovaara, I., S. Koenig, A. Y. Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177: 1567-1573. (Pubitemid 23146123)
10. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, et al. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66: 2928-2933.
11. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1994. The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J. Virol. 68: 6778-6781. (Pubitemid 24294933)
12. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. Bangham. 1995. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol. 69: 2649-2653.
13. Kubota, R., K. Hanada, Y. Furukawa, K. Arimura, M. Osame, T. Gojobori, and S. Izumo. 2007. Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs. J. Immunol. 178: 5966-5972. (Pubitemid 46674394)
14. Asquith, B., and C. R. Bangham. 2008. How does HTLV-I persist despite a strong cell-mediated immune response? Trends Immunol. 29: 4-11.
15. Bangham, C. R. M., K. Meekings, F. Toulza, B. Asquith, and G. P. Taylor. 2009. The immune control of HTLV-1 infection: selection forces and dynamics. Frontiers in Bioscience 14: 2889-2903.
16. + cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J. Gen. Virol. 86: 1515-1523.
17. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392.
18. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258.
19. Stambas, J., P. C. Doherty, and S. J. Turner. 2007. An in vivo cytotoxicity threshold for influenza A virus-specific effector and memory CD8+ T cells. J. Immunol. 178: 1285-1292. (Pubitemid 46154598)
20. Asquith, B., and C. R. Bangham. 2007. Quantifying HTLV-I dynamics. Immunol. Cell Biol. 85: 280-286.
21. Snyder, J. T., M. A. Alexander-Miller, J. A. Berzofskyl, and I. M. Belyakov. 2003. Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res. 1: 287-294.
22. + T cells: optimal soldiers in the war against viruses and tumors. Immunol. Res. 31: 13-24.
23. Kubota, R., S. S. Soldan, R. Martin, and S. Jacobson. 2002. Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient. J. Neurovirol. 8: 53-57. (Pubitemid 34196415)
24. Nagai, M., and M. Osame. 2003. Human T-cell lymphotropic virus type I and neurological diseases. J. Neurovirol. 9: 228-235. (Pubitemid 36656456)
25. + lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J. Immunol. 161: 482-488.
26. Wodarz, D., S. E. Hall, K. Usuku, M. Osame, G. S. Ogg, A. J. McMichael, M. A. Nowak, and C. R. Bangham. 2001. Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc. R. Soc. Lond. B. Biol. Sci. 268: 1215-1221. (Pubitemid 32622374)
27. Nowak, M. A., and C. R. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272: 74-79.
28. + T-cell responses against variable viruses. Proc. Biol. Sci. 271 (Suppl 3): S53-S56.
29. + T cells is unrelated to epitope specificity and is abrogated by viral escape. J. Virol. 81: 2624-2634.
30. + T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485.
31. Bihl, F., N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, C. H. Linde, et al. 2006. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. J. Immunol. 176: 4094-4101. (Pubitemid 44264388)
32. Daucher, M., D. A. Price, J. M. Brenchley, L. Lamoreaux, J. A. Metcalf, C. Rehm, E. Nies-Kraske, E. Urban, C. Yoder, D. Rock, et al. 2008. Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8+ T cells. J. Virol. 82: 4102-4114. (Pubitemid 351521245)
33. Purbhoo, M. A., D. J. Irvine, J. B. Huppa, and M. M. Davis. 2004. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5: 524-530.
34. Sykulev, Y., M. Joo, I. Vturina, T. J. Tsomides, and H. N. Eisen. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4: 565-571. (Pubitemid 26233310)
35. Christinck, E. R., M. A. Luscher, B. H. Barber, and D. B. Williams. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352: 67-70.
36. Pique, C., A. Ureta-Vidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M. C. Dokhelar. 2000. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191: 567-572.
37. + T cells in HTLV-1-associated neurologic disease. Blood 112: 2411-2420.
38. Vine, A. M., A. D. Witkover, A. L. Lloyd, K. J. Jeffery, A. Siddiqui, S. E. Marshall, M. Bunce, N. Eiraku, S. Izumo, K. Usuku, et al. 2002. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Infect. Dis. 186: 932-939.
39. + T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99: 88-94.
40. Jeffery, K. J., A. A. Siddiqui, M. Bunce, A. L. Lloyd, A. M. Vine, A. D. Witkover, S. Izumo, K. Usuku, K. I. Welsh, M. Osame, and C. R. Bangham. 2000. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol. 165: 7278-7284.
41. Lee, B., K. Tanaka, and H. Tozawa. 1989. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. Tohoku J. Exp. Med. 157: 1-11. (Pubitemid 19086129)
42. Tosswill, J. H., G. P. Taylor, J. P. Clewley, and J. N. Weber. 1998. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. J. Virol. Methods 75: 21-26.